title: How close are we to a pharmacogenomic test for clozapine-induced agranulocytosis?
authors.affiliation: MRC SGDP Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, De Crespigny Park, Denmark Hill, London, SE5 8AF, UK.
authors.forename: Moira
authors.initials: M
authors.lastname: Verbelen
authors.affiliation: MRC SGDP Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, De Crespigny Park, Denmark Hill, London, SE5 8AF, UK.|Department of Medical & Molecular Genetics, King's College London, 8th Floor Tower Wing, Guy's Hospital, Great Maze Pond, London, SE1 9RT, UK.
authors.forename: Cathryn M
authors.initials: CM
authors.lastname: Lewis
mesh_terms: D000380:Agranulocytosis / Q000139:chemically induced* / Q000235:genetics*; D014150:Antipsychotic Agents / Q000009:adverse effects*; D003024:Clozapine / Q000009:adverse effects*; D005820:Genetic Testing; D006680:HLA Antigens / Q000235:genetics; D006801:Humans; D010597:Pharmacogenetics
chemical_list: D014150:Antipsychotic Agents; D006680:HLA Antigens; D003024:Clozapine
keywords: HLA; agranulocytosis; clozapine; pharmacogenomic testing